Last reviewed · How we verify
NCT05005624
Validation of an Activities-of-daily-living Framework at Different Light Conditions
trial testing ADL performance in Presbyopia in 60 participants. Completed in 30 June 2021.
23 December 2020
Quick facts
| Lead sponsor | Democritus University of Thrace |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 July 2020 |
| Primary completion | 23 December 2020 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- ADL performance
Conditions studied
- Presbyopia — all drugs for Presbyopia →
- Near Vision — all drugs for Near Vision →
- Reading — all drugs for Reading →
- Daily Activities — all drugs for Daily Activities →
Sponsor
Democritus University of Thrace
Who can join
Adults 40 to 75, any sex, with Presbyopia or Near Vision. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary objective of this study is the construction and validation of an experimental environment for the simulation of a variety of near- and intermediate-vision activities of daily living (ADLs) in different combinations of light temperature and light intensity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development and Validation of a Lighting Facility for the Objective Assessment of the Visual Performance of Presbyopic Patients in a Series of Activities of Daily Living.
Labiris G, Panagiotopoulou EK, Ntonti P. · · 2022 · cited 3× · PMID 35651385 · DOI 10.7759/cureus.24548
Verify or expand the search:
- PubMed search for NCT05005624
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ADL performance
Trials testing the same drug.
- NCT05359380 — The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living · completed
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Democritus University of Thrace trials
Trials by the same sponsor.
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07060196 — The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration · not yet recruiting
- NCT07061431 — In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in He · NA · completed
- NCT07439835 — Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens · completed
- NCT06460389 — Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation With and Without Digital Assistance · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05005624 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Democritus University of Thrace
- Last refreshed: 4 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005624.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing